Evidence map›Paper›PMID 39382009›Full record

ArticleNanomedicine (London, England)2024

Detection of Tn-antigen in breast and prostate cancer models by VVL-labeled red dye-doped nanoparticles.

Alejandra Verhassel, Martha Kimani, Kamlesh Gidwani, Jouko Sandholm, Kornelia Gawlitza, Knut Rurack, Pirkko Härkönen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomedicine (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alejandra VerhasselInstitute of Biomedicine, University of Turku, Turku, 20520, Finland.ORCID 0009-0006-7289-2791
Martha KimaniChemical and Optical Sensing Division, Bundesanstalt für Materialforschung und -prüfung (BAM), Berlin, 12489, Germany.ORCID 0000-0002-1292-9795
Kamlesh GidwaniWestern Cancer Centre FICAN West, Turku, 20521, Finland.ORCID 0000-0002-9014-0618
Jouko SandholmTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, 20520, Finland.ORCID 0000-0003-0638-2444
Kornelia GawlitzaChemical and Optical Sensing Division, Bundesanstalt für Materialforschung und -prüfung (BAM), Berlin, 12489, Germany.ORCID 0000-0002-2043-4522
Knut RurackChemical and Optical Sensing Division, Bundesanstalt für Materialforschung und -prüfung (BAM), Berlin, 12489, Germany.ORCID 0000-0002-5589-5548
Pirkko HärkönenInstitute of Biomedicine, University of Turku, Turku, 20520, Finland.ORCID 0000-0001-9440-9971

Funding

European Union's Horizon 2020 research and innovation program under the Marie Skłodowska-Curie Action GlycoImaging: grant agreement No. 721297Ida Montinin SäätiöK. Albin Johanssons StiftelseLounais-Suomen SyöpäyhdistysPaulo Foundation and Lounais-Suomen Syöpäyhdistys (The Cancer Society of Southwestern Finland)University of Turku Graduate School (Drug Research Doctoral Programme)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antigens, Tumor-Associated, CarbohydrateBreast NeoplasmsNanoparticlesProstatic NeoplasmsBiomarkers, TumorCell Line, TumorFemaleFlow CytometryFluorescent DyesHumansMaleMicroscopy, ConfocalPlant LectinsPolystyrenesSilicon DioxideAntigens, Tumor-Associated, CarbohydrateBiomarkers, TumorFluorescent DyesPlant LectinsPolystyrenesSilicon Dioxidebreast cancer cellsfluorescence detectionlectin labelingprostate cancer cellssilica-coated polystyrene nanoparticlesTn-antigenVVL

Identifiers

PMID39382009
PMCPMC11520574

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.